When do we need competing risks methods for survival analysis in nephrology?Marlies Noordzij, Kitty J. Jager, Friedo W. Dekker et al.|Nephrology Dialysis Transplantation|2013Cited by 674
HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosisAlexius Ramcharan, Carine J.M. Doggen, Karlijn J. van Stralen et al.|Journal of Thrombosis and Haemostasis|2008Cited by 101